How Genmab A/S stacks up

GMAB · against 78 other Healthcare companies of similar size

Ranking by overall score

Top 5 and the companies ranked around GMAB

Rank	Company	Market cap	Overall	Valuation	Growth	Profitability	Risk
1	Incyte CorporationINCY · US-listed	23.8B USD	84	82	82	98	0 / 2
2	argenx SEARGX · US-listed	56.7B USD	79	42	96	93	0 / 2
3	Hansoh Pharmaceutical Group Company Limited3692.HK · Hong Kong	193.6B HKD (≈$24.8B)	78	64	74	97	0 / 2
4	Astellas Pharma Inc.4503.T · Japan	4.61T JPY (≈$31.3B)	76	93	89	87	1 / 2
4	Exelixis, Inc.EXEL · US-listed	17.9B USD	76	67	68	99	0 / 2
⋯
30	Tenet Healthcare CorporationTHC · US-listed	21.5B USD	60	95	53	90	2 / 2
30	West Pharmaceutical Services, Inc.WST · US-listed	28.6B USD	60	48	54	91	1 / 2
33	Edwards Lifesciences CorporationEW · US-listed	54.9B USD	59	47	40	83	0 / 2
33	STERIS plcSTE · US-listed	22.6B USD	59	65	56	78	1 / 2
35	Genmab A/SGMAB · US-listed	34.6B USD	58	51	68	88	2 / 2
35	STERIS plcS1TE34.SA · Brazil	101.7B BRL (≈$18.3B)	58	69	58	66	1 / 2
37	IDEXX Laboratories, Inc.IDXX · US-listed	52.9B USD	57	49	58	99	2 / 2
37	Torrent Pharmaceuticals LimitedTORNTPHARM.NS · India	1.77T INR (≈$21.2B)	57	43	68	84	2 / 2
37	Zoetis Inc.ZTS · US-listed	34.3B USD	57	83	42	95	2 / 2

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score